Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis. [electronic resource]
Producer: 20200320Description: 1639-1643 p. digitalISSN:- 1462-0332
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Biomarkers -- blood
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Giant Cell Arteritis -- diagnostic imaging
- Humans
- Immunosuppressive Agents -- administration & dosage
- Kaplan-Meier Estimate
- Magnetic Resonance Angiography
- Male
- Middle Aged
- Recurrence
- Remission Induction
- Risk Assessment -- methods
- Risk Factors
- Withholding Treatment
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.